Lacteol: Clinical Trials

5 trials of Lacteol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Recruiting 1, Terminated 1
Phase 21Completed 1

Follow Lacteol: new trials by email Literature Review of Lacteol trials Research Report on Lacteol

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)
lactobacillus LS - Antipsychotic Induced Weight Gain
Phase 3RecruitingAin Shams University1802025-04-202025-04-20
Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.
Beclomethasone, Probiotics, Placebo - Respiratory Tract Diseases, Wheezing
Phase 3CompletedUniversidade Federal de Pernambuco602014-04-012014-12-04
Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
LACTEOL® 340 mg, PLACEBO - Diarrhea-predominant Irritable Bowel Syndrome
Phase 3TerminatedForest Laboratories262010-06-012017-03-21
Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea
VSL#3, Placebo - Diarrhoea
Phase 2 / Phase 3CompletedNational Health Service, United Kingdom2312010-04-012013-04-26
Decreasing Rates of Illness in Kids (DRINK)
Lactobacillus (L.) casei - Healthy
Phase 3CompletedGeorgetown University6382006-09-012008-05-14

Conditions studied

Diarrhea (1)  ·  Respiratory Sounds (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Ain Shams University (1)  ·  Forest Laboratories (1)  ·  Georgetown University (1)  ·  National Health Service, United Kingdom (1)  ·  Universidade Federal de Pernambuco (1)

Countries

Brazil (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Daniel Merenstein, MD (1)  ·  Ivan T Shaw, PhD (1)  ·  Neil Haslam (1)

Results publications

PMID 23618760